Reference health
Ionic Ruthenium and Iron Based Complexes Bearing Silver Containing Anions as a Potent New Class of Anticancer Agents
48/48 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 48 checked references that resolve
resolves10.1038/205698a0
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
resolves10.1200/JCO.1983.1.10.621
Phase I study of carboplatin given on a five-day intravenous schedule.
resolves10.1080/15384047.2015.1026481
A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer
resolves10.1021/jm00210a029
Antitumor activity of 1,2-diaminocyclohexaneplatinum complexes against Sarcoma-180 ascites form
resolves10.1093/oxfordjournals.annonc.a010489
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
resolves10.1200/JCO.1994.12.10.2066
Long-term follow-up of the first randomized study of cisplatin versus carboplatin for advanced epithelial ovarian cancer.
resolves10.1016/S0959-8049(96)00370-X
Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer
resolves10.1039/c0dt00292e
The status of platinum anticancer drugs in the clinic and in clinical trials
resolves10.2174/187152007779314017
Searching for the Magic Bullet: Anticancer Platinum Drugs Which Can Be Accumulated or Activated in the Tumor Tissue
resolves10.1021/om500965k
Organometallic Titanocene–Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties
resolves10.1021/ic201647h
Titanocene–Phosphine Derivatives as Precursors to Cytotoxic Heterometallic TiAu<sub>2</sub>and TiM (M = Pd, Pt) Compounds. Studies of Their Interactions with DNA
resolves10.1016/j.jinorgbio.2013.07.033
Important cytotoxicity of novel iron(II) cyclopentadienyl complexes with imidazole based ligands
resolves10.1016/j.jorganchem.2014.01.027
New iron(II) cyclopentadienyl derivative complexes: Synthesis and antitumor activity against human leukemia cancer cells
resolves10.1016/j.jorganchem.2017.10.004
New iron cyclopentadienyl complexes bearing different phosphane co-ligands: Structural factors vs. cytotoxicity
resolves10.1158/1078-0432.CCR-03-0746
A Phase I and Pharmacological Study with Imidazolium-<b>
<i>trans-</i>
</b>DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent
resolves10.1016/j.jinorgbio.2006.02.013
From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
resolves10.1039/C4SC01255K
<i>In vivo</i>
anti-tumor activity of the organometallic ruthenium(
<scp>ii</scp>
)-arene complex [Ru(η
<sup>6</sup>
-
<i>p</i>
-cymene)Cl
<sub>2</sub>
(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas
resolves10.1016/j.jphotobiol.2013.12.014
Synthesis, crystal structures, in vitro DNA binding, antibacterial and cytotoxic activities of new di- and polynuclear silver(I) saccharinate complexes with tertiary monophosphanes
resolves10.1007/s10534-014-9817-5
The induction of cell death by phosphine silver(I) thiocyanate complexes in SNO-esophageal cancer cells
resolves10.1007/s10534-015-9865-5
The effect of 1:2 Ag(I) thiocyanate complexes in MCF-7 breast cancer cells
resolves10.1016/j.jorganchem.2017.04.009
Access to silver-NHC complexes from soluble silver species in aqueous or ethanolic ammonia
resolves10.2174/1871520617666170522123742
A Comparison of the Toxicity of Mono, Bis, Tris and Tetrakis Phosphino Silver Complexes on SNO Esophageal Cancer Cells
resolves10.1007/s10534-017-0051-9
The ability of silver(I) thiocyanate 4-methoxyphenyl phosphine to induce apoptotic cell death in esophageal cancer cells is correlated to mitochondrial perturbations
resolves10.1039/C5DT01614B
Design, synthesis and characterisation of new chimeric ruthenium(
<scp>ii</scp>
)–gold(
<scp>i</scp>
) complexes as improved cytotoxic agents
resolves10.1016/j.jinorgbio.2014.07.011
New heteronuclear gold(I)–platinum(II) complexes with cytotoxic properties: Are two metals better than one?
resolves10.1016/j.jorganchem.2019.120934
Heterobimetallic Ru(μ-dppm)Fe and homobimetallic Ru(μ-dppm)Ru complexes as potential anti-cancer agents
resolves10.1021/om049665q
Mechanistic Investigations on the Hydrogenation of Alkenes Using Ruthenium(II)-arene Diphosphine Complexes
resolves10.1016/S0022-328X(00)98971-X
Alkylidenverbrückte diphosphane und dichlalkogenodiphosphorane als liganden in kationischen cyclopentadienyleisencarbonyl-komplexen
resolves10.1039/b508541a
Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn: Design and assessment of accuracy
resolves10.1002/jcc.21759
Effect of the damping function in dispersion corrected density functional theory
resolves10.1063/1.3382344
A consistent and accurate<i>ab initio</i>parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu
resolves10.1038/s41420-019-0139-9
The palladacycle complex AJ-5 induces apoptotic cell death while reducing autophagic flux in rhabdomyosarcoma cells
resolves10.1016/j.canlet.2014.11.027
The palladacycle, AJ-5, exhibits anti-tumour and anti-cancer stem cell activity in breast cancer cells
resolves10.1016/j.jinorgbio.2019.110975
Anticancer and antimetastatic activity of copper(II)-tropolone complex against human breast cancer cells, breast multicellular spheroids and mammospheres
resolves10.1016/j.jinorgbio.2019.110910
An Erlotinib gold(I) conjugate for combating triple-negative breast cancer
resolves10.1016/j.jorganchem.2020.121214
Facile entry to germanate and stannate complexes [(η6-arene)RuCl(η2-dppm)]+[ECl3]- (E = Ge, Sn) as potent anti-cancer agents
The 3 references without a DOI — listed, not checked
no DOI — not checked10.1016/j.jorganchem.2020.121659_bib0003a
no DOI — not checked10.1016/j.jorganchem.2020.121659_bib0003c
no DOI — not checked10.1016/j.jorganchem.2020.121659_bib0014c
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.jorganchem.2020.121659"><img src="https://citestamp.com/citestamped/10.1016/j.jorganchem.2020.121659/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.jorganchem.2020.121659)